山东中医杂志2018，Vol.37Issue(5)：378-380,3.DOI:10.16295/j.cnki.0257-358x.2018.05.008
胃康I号方治疗中虚气逆型反流性食管炎临床观察
Observation on Reflux Esophagitis of Middle Deficiency and Qi Rebellion Treated with Weikang Ⅰ Formula
倪小燕 1安祯祥2
作者信息
- 1. 贵阳中医学院,贵州 贵阳 550002
- 2. 贵州省中医院,贵州 贵阳 550001
- 折叠
摘要
Abstract
Objective:To observe the clinical efficacy of Weikang Ⅰ formula combined rabeprazole sodium enteric-coated capsule on reflux esophagitis(RE) of middle deficiency and qi rebellion type. Method:Sixty patients with RE were randomly divided into the control group and the treatment group, 30 cases in each group by a random number table. Patients in both two groups were given rabeprazole sodium enteric-coated capsule 20 mg in the morning and evening, and patients in the treatment group was also given Weikang Ⅰformula, 1 dose Ya day. In the two groups, the treatment lasted for 8 weeks and the clinical efficacy was observed. Results:The clinical effect of syndromes and the effect on inflammation under gastroscopy in the treatment group were better than those in the control group, with statistical difference(P＜0.05). The treatment group was lower than the control group on the traditional Chinese medicine symptom score, GerdQ score, with significant difference(P＜0.01). At 6-month follow-up, the recurrence rate in the treatment group was 21.4％ and was significantly lower than that in the control group 52.4％(P＜0.05). Conclusion:Weikang Ⅰformula combined with rabeprazole sodium enteric-coated capsule showed better curative effect for RE. It could alleviate the clinical symptom and reduce the recurrence rate.关键词
反流性食管炎/胃康I号方/联合治疗/雷贝拉唑钠肠溶胶囊Key words
reflux esophagitis/Weikang Ⅰ formula/combined treatment/rabeprazole sodium enteric-coated capsule分类
医药卫生引用本文复制引用
倪小燕,安祯祥..胃康I号方治疗中虚气逆型反流性食管炎临床观察[J].山东中医杂志,2018,37(5):378-380,3.
